Alpha-Defensin vs MGF (Mechano Growth Factor)

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Alpha-Defensin

Alpha-defensins are small cationic peptides that are key components of the innate immune system. They have broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses.

Full details →

MGF (Mechano Growth Factor)

MGF (Mechano Growth Factor) is a splice variant of IGF-1 that is produced locally in muscle tissue in response to mechanical stress. The non-PEGylated form has a very short half-life.

Full details →

Side-by-Side Comparison

AspectAlpha-DefensinMGF (Mechano Growth Factor)
MechanismInsert into microbial membranes to form pores, leading to cell death. Also have immunomodulatory effects including chemotaxis of immune cells and cytokine modulation.Activates muscle satellite cells (stem cells) and promotes their proliferation without differentiation, priming them for fusion with existing muscle fibers during repair and growth.
Typical DosageResearch compound - dosing varies by application. Typically studied in laboratory and early clinical research settings rather than for general use.Due to extremely short half-life (minutes), typical protocols use 100-200mcg injected directly into target muscles immediately post-workout.
AdministrationVarious routes studied including topical, local injection, and systemic administration depending on application.Intramuscular injection into trained muscles within minutes of workout completion. Must be used immediately after reconstitution due to instability.
Side EffectsLimited human use data. May cause local inflammation. Potential for immune activation effects.Injection site soreness, potential hypoglycemia, localized swelling. Short half-life limits systemic effects.
Best For

What They Have in Common

Both Alpha-Defensin and MGF (Mechano Growth Factor) are commonly used for:

Key Differences

Unique to Alpha-Defensin:

Unique to MGF (Mechano Growth Factor):

Ready to Learn More?